149 related articles for article (PubMed ID: 24420925)
1. Effects of triptolide on the pharmacokinetics of cyclophosphamide in rats: a possible role of cytochrome P3A4 inhibition.
Zhang XF; Liu J; Ye F; Ji SG; Zhang N; Cao RS; He L; Wu JC; Li XF
Chin J Integr Med; 2014 Jul; 20(7):534-9. PubMed ID: 24420925
[TBL] [Abstract][Full Text] [Related]
2. The effects of triptolide on the pharmacokinetics of sorafenib in rats and its potential mechanism.
Wang X; Zhang X; Liu F; Wang M; Qin S
Pharm Biol; 2017 Dec; 55(1):1863-1867. PubMed ID: 28614959
[TBL] [Abstract][Full Text] [Related]
3. Glycyrrhizin accelerates the metabolism of triptolide through induction of CYP3A in rats.
Tai T; Huang X; Su Y; Ji J; Su Y; Jiang Z; Zhang L
J Ethnopharmacol; 2014 Mar; 152(2):358-63. PubMed ID: 24486211
[TBL] [Abstract][Full Text] [Related]
4. Role of CYP3A in regulating hepatic clearance and hepatotoxicity of triptolide in rat liver microsomes and sandwich-cultured hepatocytes.
Shen G; Zhuang X; Xiao W; Kong L; Tan Y; Li H
Food Chem Toxicol; 2014 Sep; 71():90-6. PubMed ID: 24910460
[TBL] [Abstract][Full Text] [Related]
5. CYP3A4 inducer and inhibitor strongly affect the pharmacokinetics of triptolide and its derivative in rats.
Xu Y; Zhang YF; Chen XY; Zhong DF
Acta Pharmacol Sin; 2018 Aug; 39(8):1386-1392. PubMed ID: 29283173
[TBL] [Abstract][Full Text] [Related]
6. In vivo effect of triptolide combined with glycyrrhetinic acid on rat cytochrome P450 enzymes.
Han FM; Peng ZH; Wang JJ; Chen Y
Yao Xue Xue Bao; 2013 Jul; 48(7):1136-41. PubMed ID: 24133982
[TBL] [Abstract][Full Text] [Related]
7. Effects of ketoconazole on cyclophosphamide metabolism: evaluation of CYP3A4 inhibition effect using the in vitro and in vivo models.
Yang L; Yan C; Zhang F; Jiang B; Gao S; Liang Y; Huang L; Chen W
Exp Anim; 2018 Feb; 67(1):71-82. PubMed ID: 29129847
[TBL] [Abstract][Full Text] [Related]
8. Herb-drug interaction between Styrax and warfarin: Molecular basis and mechanism.
Zhang F; Huang J; He RJ; Wang L; Huo PC; Guan XQ; Fang SQ; Xiang YW; Jia SN; Ge GB
Phytomedicine; 2020 Oct; 77():153287. PubMed ID: 32739573
[TBL] [Abstract][Full Text] [Related]
9. Effect of CYP3A4 on liver injury induced by triptolide.
Xiao X; Zhang T; Huang J; Zhao Q; Li F
Biomed Chromatogr; 2020 Aug; 34(8):e4864. PubMed ID: 32330997
[TBL] [Abstract][Full Text] [Related]
10. Screening and verification of CYP3A4 inhibitors from Bushen-Yizhi formula to enhance the bioavailability of osthole in rat plasma.
Liu JM; Chen JM; Lin MJ; Wu FC; Ma CR; Zuo X; Yu WQ; Huang MJ; Fang JS; Li WR; Wang Q; Liang Y
J Ethnopharmacol; 2022 Jan; 282():114643. PubMed ID: 34534597
[TBL] [Abstract][Full Text] [Related]
11. Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of nifedipine in rats: Possible role of P-gp and CYP3A4 inhibition by HMG-CoA reductase inhibitors.
Lee CK; Choi JS; Choi DH
Pharmacol Rep; 2015 Feb; 67(1):44-51. PubMed ID: 25560574
[TBL] [Abstract][Full Text] [Related]
12. Effects of cytochrome P4503A inducer dexamethasone on the metabolism and toxicity of triptolide in rat.
Ye X; Li W; Yan Y; Mao C; Cai R; Xu H; Yang X
Toxicol Lett; 2010 Feb; 192(2):212-20. PubMed ID: 19879934
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of continuous ingestion of Schisandrin A on CYP3A in the rat.
Li WL; Xin HW; Su MW
Basic Clin Pharmacol Toxicol; 2012 Feb; 110(2):187-92. PubMed ID: 21895978
[TBL] [Abstract][Full Text] [Related]
14. Effects of triptolide on pharmacokinetics of amlodipine in rats by using LC-MS/MS.
Zhang C; Gao Z; Niu L; Chen X
Pharm Biol; 2018 Dec; 56(1):132-137. PubMed ID: 29385884
[TBL] [Abstract][Full Text] [Related]
15. Effects of ketoconazole and rifampicin on the pharmacokinetics of GLS4, a novel anti-hepatitis B virus compound, in dogs.
Zhou X; Gao ZW; Meng J; Chen XY; Zhong DF
Acta Pharmacol Sin; 2013 Nov; 34(11):1420-6. PubMed ID: 24056704
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the roles of P-glycoprotein and cytochrome P450 in triptolide-induced liver toxicity in sandwich-cultured rat hepatocyte model.
Zhuang XM; Shen GL; Xiao WB; Tan Y; Lu C; Li H
Drug Metab Dispos; 2013 Dec; 41(12):2158-65. PubMed ID: 24065861
[TBL] [Abstract][Full Text] [Related]
17. Triptolide Induces hepatotoxicity via inhibition of CYP450s in Rat liver microsomes.
Lu Y; Xie T; Zhang Y; Zhou F; Ruan J; Zhu W; Zhu H; Feng Z; Zhou X
BMC Complement Altern Med; 2017 Jan; 17(1):15. PubMed ID: 28056947
[TBL] [Abstract][Full Text] [Related]
18. Triptolide and atorvastatin synergistically promote hepatotoxicity in cultured hepatocytes and female Sprague-Dawley rats by inhibiting pregnane X receptor-mediated transcriptional activation of CYP3A4.
Zheng N; Wei A; Wu T; Long L; Yang H; Li H; Wang L
Toxicol Lett; 2021 May; 342():85-94. PubMed ID: 33600922
[TBL] [Abstract][Full Text] [Related]
19. Variation in the Response of Clozapine Biotransformation Pathways in Human Hepatic Microsomes to CYP1A2- and CYP3A4-selective Inhibitors.
Murray M; Zhang WV; Edwards RJ
Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):388-395. PubMed ID: 29155491
[TBL] [Abstract][Full Text] [Related]
20. Effects of nifedipine on the pharmacokinetics of repaglinide in rats: possible role of CYP3A4 and P-glycoprotein inhibition by nifedipine.
Choi JS; Choi I; Choi DH
Pharmacol Rep; 2013; 65(5):1422-30. PubMed ID: 24399740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
